IRIS
COLUSSI, Gian Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.861
AS - Asia 5.836
EU - Europa 4.408
SA - Sud America 1.135
Continente sconosciuto - Info sul continente non disponibili 612
AF - Africa 124
OC - Oceania 9
Totale 26.985
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.600
SG - Singapore 2.840
CN - Cina 1.169
UA - Ucraina 1.131
IT - Italia 1.013
BR - Brasile 876
HK - Hong Kong 614
DE - Germania 570
FI - Finlandia 432
VN - Vietnam 357
RU - Federazione Russa 302
FR - Francia 265
IE - Irlanda 201
TR - Turchia 165
IN - India 155
GB - Regno Unito 142
CA - Canada 126
SE - Svezia 125
BD - Bangladesh 124
AR - Argentina 103
KR - Corea 71
IQ - Iraq 53
MX - Messico 53
CO - Colombia 42
JP - Giappone 40
NL - Olanda 39
PK - Pakistan 38
EC - Ecuador 36
ID - Indonesia 29
PL - Polonia 29
ZA - Sudafrica 29
BE - Belgio 28
ES - Italia 27
UZ - Uzbekistan 25
VE - Venezuela 25
AT - Austria 23
MA - Marocco 22
SA - Arabia Saudita 20
EU - Europa 19
IR - Iran 18
EG - Egitto 16
CL - Cile 15
CZ - Repubblica Ceca 15
LB - Libano 15
JO - Giordania 14
PE - Perù 14
TT - Trinidad e Tobago 14
CR - Costa Rica 13
KE - Kenya 13
JM - Giamaica 12
DZ - Algeria 10
MY - Malesia 10
EE - Estonia 9
IL - Israele 9
PY - Paraguay 9
TN - Tunisia 9
CH - Svizzera 8
HN - Honduras 8
OM - Oman 8
AE - Emirati Arabi Uniti 7
AU - Australia 7
BO - Bolivia 7
GT - Guatemala 7
PH - Filippine 7
UY - Uruguay 7
NP - Nepal 6
AZ - Azerbaigian 5
GP - Guadalupe 5
NI - Nicaragua 5
PR - Porto Rico 5
RS - Serbia 5
AL - Albania 4
KZ - Kazakistan 4
LT - Lituania 4
PS - Palestinian Territory 4
PT - Portogallo 4
RO - Romania 4
SK - Slovacchia (Repubblica Slovacca) 4
TG - Togo 4
TH - Thailandia 4
BW - Botswana 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GE - Georgia 3
GR - Grecia 3
PA - Panama 3
QA - Qatar 3
SV - El Salvador 3
TW - Taiwan 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BT - Bhutan 2
BZ - Belize 2
CM - Camerun 2
HU - Ungheria 2
KW - Kuwait 2
LK - Sri Lanka 2
LV - Lettonia 2
Totale 26.356
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.428
Ashburn 1.240
Singapore 1.197
Fairfield 1.111
Ann Arbor 912
San Jose 908
Jacksonville 799
Hong Kong 612
Chandler 594
Houston 589
Beijing 554
Council Bluffs 522
Dearborn 501
Wilmington 496
Seattle 458
Cambridge 371
Boardman 294
Princeton 220
Dublin 198
Lauterbourg 197
Los Angeles 186
Udine 150
Dallas 122
Buffalo 113
Izmir 109
Santa Clara 109
Ho Chi Minh City 92
Hefei 91
San Diego 87
Milan 85
Hanoi 84
São Paulo 82
New York 77
Helsinki 75
Seoul 60
Redondo Beach 59
The Dalles 58
Des Moines 51
Munich 50
Ogden 48
Dong Ket 47
Rome 45
Norwalk 44
Redmond 42
Ottawa 40
Tokyo 38
Nanjing 37
Orem 37
Phoenix 37
Mumbai 35
Frankfurt am Main 33
San Mateo 32
Atlanta 31
Kunming 30
Rio de Janeiro 29
Nuremberg 28
Warsaw 27
Baghdad 26
Brussels 26
Guangzhou 26
Brooklyn 25
Chicago 25
Pittsburgh 24
Toronto 24
Belo Horizonte 23
London 23
San Francisco 23
Denver 21
Montreal 21
North Bergen 21
Johannesburg 20
Tashkent 20
Amsterdam 19
Ankara 19
Trieste 19
Chennai 18
Dhaka 18
Shanghai 18
Stockholm 17
Manchester 16
Quito 16
Boston 15
Washington 15
Charlotte 14
Goiânia 14
Vienna 14
Brasília 13
Mcallen 13
New Delhi 13
Porto Alegre 13
Reggio Emilia 13
Amman 12
Brno 12
Grafing 12
Jinan 12
Mexico City 12
Nairobi 12
Poplar 12
Bogotá 11
Bologna 11
Totale 16.352
Salva come PNG Salva come JPEG
Nome #
Decreased fibrinolytic activity is associated with carotid artery stiffening in arterial hypertension 276
Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies 254
Aldosterone and the heart: from basic research to clinical evidence 219
Aldosterone and Left Ventricular Remodeling 208
Early renal failure as a cardiovascular disease: Focus on lipoprotein(a) and prothrombotic state 196
Aldosterone and the heart: still an unresolved issue? 194
Impact of omega-3 polyunsaturated fatty acids on vascular function and blood pressure: relevance for cardiovascular outcomes 190
Omega-3 Fatty Acids: from Biochemistry to their Clinical Use in the Prevention of Cardiovascular Disease 189
Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension 188
Long-Term Renal and Cardiac Outcomes after Stenting in Patients with Resistant Hypertension and Atherosclerotic Renal Artery Stenosis 187
Vasculite dei vasa-nervorum: risposta alla terapia immunosoppressiva. Case Report 184
Aldosterone, Organ Damage, and Dietary Salt 183
Role of Aldosterone in Insulin Resistance: Fact of Fantasy 182
Relationships of plasma renin levels with renal function in patients with primary aldosteronism 181
Moderate alcohol consumption is associated with left ventricular diastolic dysfunction in nonalcoholic hypertensive patients 177
Salt, hypertension, and cardiovascular disease 176
Benzodiazepines regulate the vascular tone vie an endothelium-independent mechanism 176
Fish Meal Supplementation and Ambulatory Blood Pressure in Patients With Hypertension: Relevance of Baseline Membrane Fatty Acid Composition 174
A Prothrombotic State is Associated with Early Arterial Damage in Hypertensive Patients 172
Elevated homocysteine levels are associated with the metabolic syndrome and cardiovascular events in hypertensive patients 172
Diabetes, diabetic complications, and blood pressure targets 171
Relationship of Plasma Renin With a Prothrombotic State in Hypertension: Relevance for Organ Damage 170
Pre-Procedural Statin Use Is Associated with Improved Long-Term Survival and Reduced Major Cardiovascular Events in Patients Undergoing Carotid Artery Stenting: A Retrospective Study 170
Editorial comment from Dr Catena, Dr Colussi, and Dr Sechi to preoperative masse renal damage in japanese patients with primry aldosteronism: identification of predictors for chronic kidney disease manifested after adrenalectomy. 166
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 166
Salt, Aldosterone, and Parathyroid Hormone: What Is the Relevance for Organ Damage? 165
The emergent cardiovascular risk factors and organ damage in arterial hypertension 164
Treatment of primary aldosteronism and organ protection 164
Intrarenal Vascular Resistance is Associated with a Prothrombotic State in Hypertensive Patients 163
Cardiovascular outcomes in patients with primary aldosteronism after treatment 163
Involvement of endothelium-dependent and -independent mechanisms in midazolam-induced vasodilation 162
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 160
The Metabolic Syndrome and the Membrane Content of Polyunsaturated Fatty Acids in Hypertensive Patients 160
Aldosterone plasmatico e escrezione urinaria di albumina nell’ipertensione arteriosa 158
A prothrombotic state is associated with increased carotid intima-media thickness in hypertension 158
Glucocorticoid-induced leucine zipper protein regulates sodium and potassium balance in the distal nephron 156
Omega-3 Polyunsaturated Fatty Acids in the Treatment of Non-Alcoholic Fatty Liver Disease: Are They So Good? 154
Elevated Blood Pressure in Children of Cardiovascular Risk Mothers: Could Maternal Folic Acid Be the Link? 154
Effects of the consumption of fish meals on the carotid IntimaMedia thickness in patients with hypertension: a prospective study 151
The vascular response to vasodilators is related to the membrane content of polyunsaturated fatty acids in hypertensive patients 151
Mineralocorticoid Receptor Antagonists and Clinical Outcomes in Primary Aldosteronism: As Good as Surgery? 149
Benzodiazepines: an old class of new antihypertensive drugs? 149
Renal function in primary aldosteronism 148
Evaluation of endothelial function in patients with non-alcoholic fatty liver disease 148
Carotid artery stiffness is related to hyperinsulinemia and insulin-resistance in middle-aged, non-diabetic hypertensive patients 148
Potassium-sparing diuretics in hypertension 146
Kidney in primary aldosteronism: a key determinant of treatment outcome 146
New risk factors for atherosclerosis in hypertension: focus on the prothrombotic state and lipoprotein(a) 144
Impact of statin therapy on plasma levels of plasminogen activator inhibitor-1: A systematic review and meta-analysis of randomised controlled trials 144
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società  Italiana di Medicina Interna) Study 144
AORTIC STIFFNESS AND INDEXES OF DISEASE SEVERITY IN SUBJECTS WITH PREVIOUS COVID-19 PNEUMONIA: A FOLLOW-UP STUDY 143
Endothelial function in patients with non-alcoholic fatty liver disease 143
Association of Post-Saline Load Plasma Aldosterone Levels with Left Ventricular Hypertrophy in Primary Hypertension 143
Association of aldosterone with left ventricular mass in hypertension: interaction with plasma fibrinogen levels 142
Atrial fibrillation and its complications in arterial hypertension: The potential preventive role of ω-3 polyunsaturated fatty acids 141
Relationships of plasma lipoprotein(a) levels with insulin resistance in hypertensive patients 140
Uricaemia and left ventricular mass in hypertensive patients 140
RELATIONSHIPS BETWEEN NAFLD BIOCHEMICAL SCORES AND LEFT VENTRICULAR GEOMETRIC PATTERN IN NAÏVE ESSENTIAL HYPERTENSIVE PATIENTS 139
Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension 139
Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment 138
ACIDI GRASSI POLIINSATURI OMEGA-3 E FATTORI DI RISCHIO CARDIOVASCOLARE 138
The Rising Burden of Hypertensive Renal Disease in Low-Income Countries: Is it Time to Take Action? 138
Effect of heparin treatment on pulmonary embolism and in-hospital death in unvaccinated COVID-19 patients without overt deep vein thrombosis 138
Ambulatory blood pressure and left ventricular geometry in patients with myotonic dystrophy 137
Insulin sensitivity in patients with primary aldosteronism: a follow-up study 136
Subclinical carotid artery disease and plasma homocysteine levels in patients with hypertension 136
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 136
Hypertension and type 2 diabetes: lights and shadows about causality 136
Renal function in primary aldosteronism: revisiting the concept of “renin escape” 135
Plasma glucose levels and left ventricular diastolic function in nondiabetic hypertensive patients 133
Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients 133
Alpha-adducin gene polymorphism predicts cardiac and vascular response to treatment in hypertensive women 132
Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients: Response to Perciaccante et al. [4] 132
Association of elevated levels of PAI-1 with insulin resistance and inflammatory markers in hypertension. 131
Studio della funzione endoteliale in pazienti con steatosi epatica non-alcolica. 131
Relationships of plasma renin with renal function in primary aldosteronism: revisiting the concept of renin escape 130
Aldosterone and aldosterone antagonists in cardiac disease: what is known, what is new 130
Omega-3 polyunsaturated fatty acids in blood pressure control and essential hypertension 130
Plasma lipoprotein(a) levels and atherosclerotic renal artery stenosis in hypertensive patients 129
Abnormal 24-hour blood pressure profile and left ventricular geometry in patients with myotonic dystrophy 129
Association of a prothrombotic state with the metabolic syndrome in essential hypertensive patients 128
Mineralocorticoid receptor antagonists and renal involvement in primary aldosteronism: opening of a new era 128
Dulaglutide reduces binge episodes in type 2 diabetic patients with binge eating disorder: A pilot study 128
Associazione dell’ispessimento miointimale carotideo con uno stato protrombotico in pazienti ipertesi 127
Response to "plasma Homocysteine Levels and Endothelial Dysfunction in Cerebro-and Cardiovascular Diseases in the Metabolic Syndrome" 127
. L’attività fisica migliora la sensibilità all’insulina ed i fattori di rischio protrombotico in una popolazione di pazienti ipertesi 126
Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment 126
Effects of omega-3 PUFA on plasma lipoprotein(a) in hypertensive patients 125
The new cardiovascular risk factors in hypertensive patients with metabolic syndrome 125
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 125
The carotid intima-media thickness and cardiac tissue Doppler in hypertension 124
Reversal of left ventricular hypertrophy after treatment is related to severity of disease in patients with primary aldosteronism 124
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 124
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 124
Cardiac and renal damage in primary aldosteronism 122
Association of a prothrombotic state with carotid intima-media thickness in hypertensive patients 122
Functioning or Non-Functioning Adrenal Adenoma? Probably, Just a Matter of Time 122
Prognostic role of malnutrition diagnosed by bioelectrical impedance vector analysis in older adults hospitalized with covid-19 pneumonia: A prospective study 122
Long-term out come of renal cysts in patients with primary aldosteronism 120
Mineralocorticoid Antagonists Treatment Versus Surgery in Primary Aldosteronism 120
Totale 15.137
Salva come PNG Salva come JPEG
Categoria #
all - tutte 107.897
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.897
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.149 0 0 0 0 47 55 85 96 22 256 307 281
2022/20231.649 251 95 31 184 139 486 6 92 234 24 55 52
2023/2024520 91 32 41 9 82 58 23 12 70 20 8 74
2024/20253.580 80 265 141 116 72 155 173 186 415 294 638 1.045
2025/20266.972 476 714 543 601 1.065 557 955 225 542 600 442 252
2026/20272.218 101 521 584 957 55 0 0 0 0 0 0 0
Totale 26.985